These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 34461162

  • 1. Comparative effectiveness of endovascular treatment modalities for de novo femoropopliteal lesions in intermittent claudication: A network meta-analysis of randomized controlled trials.
    Zhou Y, Wang J, He H, Li Q, Li M, Li X, Shu C.
    Int J Cardiol; 2021 Nov 15; 343():122-130. PubMed ID: 34461162
    [Abstract] [Full Text] [Related]

  • 2. Comparative effectiveness of endovascular treatment modalities for de novo femoropopliteal lesions at long-term follow-up: A network meta-analysis of randomized controlled trials.
    Zhou Y, Wang T, He H, Li Q, Wan Z, Lu P, Shu C.
    Int J Cardiol; 2024 Jun 01; 404():131977. PubMed ID: 38508322
    [Abstract] [Full Text] [Related]

  • 3. Comparative Effectiveness of Endovascular Treatment Modalities for De Novo Femoropopliteal Lesions: A Network Meta-analysis of Randomized Controlled Trials.
    Zhou Y, Zhang Z, Lin S, Xiao J, Ai W, Wang J, Li Y, Li Q.
    J Endovasc Ther; 2020 Feb 01; 27(1):42-59. PubMed ID: 31948375
    [Abstract] [Full Text] [Related]

  • 4. The safety and efficacy of different endovascular treatments for in-stent restenosis of the femoropopliteal artery: A network meta-analysis.
    He Z, Wang H, Lin F, Ding W, Chen K, Zhang Z.
    Vasc Med; 2022 Jun 01; 27(3):239-250. PubMed ID: 35164613
    [Abstract] [Full Text] [Related]

  • 5. Network Meta-Analysis of All Available Regimens Based on Drug-Coated Balloon Angioplasty and Laser Atherectomy for Femoropopliteal In-Stent Restenosis.
    Yu C, Tang W, Ren T, Chen Q, Lu R, Gao Y.
    J Endovasc Ther; 2024 Jun 01; 31(3):390-399. PubMed ID: 36189843
    [Abstract] [Full Text] [Related]

  • 6. Directional atherectomy and drug-coated balloon angioplasty vs. bare nitinol stent angioplasty for femoropopliteal artery lesions.
    Wei L, Guo J, Guo L, Qi L, Cui S, Tong Z, Hou P, Gu Y.
    Vasa; 2022 Sep 01; 51(5):275-281. PubMed ID: 35801303
    [Abstract] [Full Text] [Related]

  • 7. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes.
    Kokkinidis DG, Behan S, Jawaid O, Hossain P, Giannopoulos S, Singh GD, Laird JR, Valle JA, Waldo SW, Armstrong EJ.
    Catheter Cardiovasc Interv; 2020 Feb 15; 95(3):439-446. PubMed ID: 31816169
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease.
    Imran HM, Hyder ON, Soukas PA.
    Cardiovasc Revasc Med; 2019 Mar 15; 20(3):210-214. PubMed ID: 29970328
    [Abstract] [Full Text] [Related]

  • 9. Endovascular revascularization strategies for aortoiliac and femoropopliteal artery disease: a meta-analysis.
    Koeckerling D, Raguindin PF, Kastrati L, Bernhard S, Barker J, Quiroga Centeno AC, Raeisi-Dehkordi H, Khatami F, Niehot C, Lejay A, Szeberin Z, Behrendt CA, Nordanstig J, Muka T, Baumgartner I.
    Eur Heart J; 2023 Mar 14; 44(11):935-950. PubMed ID: 36721954
    [Abstract] [Full Text] [Related]

  • 10. Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease.
    Caradu C, Lakhlifi E, Colacchio EC, Midy D, Bérard X, Poirier M, Ducasse E.
    J Vasc Surg; 2019 Sep 14; 70(3):981-995.e10. PubMed ID: 31126769
    [Abstract] [Full Text] [Related]

  • 11. Midterm Outcome of Directional Atherectomy Combined with Drug-Coated Balloon Angioplasty Versus Drug-Coated Balloon Angioplasty Alone for Femoropopliteal Arteriosclerosis Obliterans.
    Cai Z, Guo L, Qi L, Cui S, Tong Z, Guo J, Wang Z, Gu Y.
    Ann Vasc Surg; 2020 Apr 14; 64():181-187. PubMed ID: 31449956
    [Abstract] [Full Text] [Related]

  • 12. Meta-Analysis Comparing Endovascular Treatment Modalities for Femoropopliteal Peripheral Artery Disease.
    Khan MS, Zou F, Khan AR, Moustafa A, Schmid CH, Baig M, Hyder ON, Aronow HD.
    Am J Cardiol; 2020 Aug 01; 128():181-188. PubMed ID: 32650917
    [Abstract] [Full Text] [Related]

  • 13. Comparison of Different Endovascular Treatments of Femoropopliteal Artery In-Stent Restenosis: A Systematic Review and Bayesian Network Meta-Analysis.
    Wang H, Wu S, D'Oria M, Pan D, Hu L, Zhang H, Guo J, Gu Y.
    Ann Vasc Surg; 2024 Jul 01; 104():205-216. PubMed ID: 38492725
    [Abstract] [Full Text] [Related]

  • 14. Comparative Efficacy and Safety of Endovascular Treatment Modalities for Femoropopliteal Artery Lesions: A Network Meta-analysis of Randomized Controlled Trials.
    Zhou Y, Zhang Z, Lin S, Xiao J, Ai W, Wang J, Li Y, Li Q.
    Cardiovasc Intervent Radiol; 2020 Feb 01; 43(2):204-214. PubMed ID: 31646376
    [Abstract] [Full Text] [Related]

  • 15. Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency: Twelve-Month Results of the DEFINITIVE AR Study.
    Zeller T, Langhoff R, Rocha-Singh KJ, Jaff MR, Blessing E, Amann-Vesti B, Krzanowski M, Peeters P, Scheinert D, Torsello G, Sixt S, Tepe G, DEFINITIVE AR Investigators.
    Circ Cardiovasc Interv; 2017 Sep 01; 10(9):e004848. PubMed ID: 28916599
    [Abstract] [Full Text] [Related]

  • 16. Network meta-analysis of drug-coated balloon angioplasty versus primary nitinol stenting for femoropopliteal atherosclerotic disease.
    Abdoli S, Mert M, Lee WM, Ochoa CJ, Katz SG.
    J Vasc Surg; 2021 May 01; 73(5):1802-1810.e4. PubMed ID: 33249205
    [Abstract] [Full Text] [Related]

  • 17. Primary Drug-Coated Balloon Versus Drug-Eluting Stent for Native Atherosclerotic Femoropopliteal Lesions: A Systematic Review and Meta-Analysis.
    Zenunaj G, Traina L, Acciarri P, Mario Cosacco A, Alesiani F, Baldazzi G, Gasbarro V.
    Ann Vasc Surg; 2023 May 01; 92():294-303. PubMed ID: 36746268
    [Abstract] [Full Text] [Related]

  • 18. Nationwide trends in drug-coated balloon and drug-eluting stent utilization in the femoropopliteal arteries.
    Mohapatra A, Saadeddin Z, Bertges DJ, Madigan MC, Al-Khoury GE, Makaroun MS, Eslami MH.
    J Vasc Surg; 2020 Feb 01; 71(2):560-566. PubMed ID: 31405761
    [Abstract] [Full Text] [Related]

  • 19. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Isolated Popliteal Artery Lesions.
    Stavroulakis K, Schwindt A, Torsello G, Stachmann A, Hericks C, Bosiers MJ, Beropoulis E, Stahlhoff S, Bisdas T.
    J Endovasc Ther; 2017 Apr 01; 24(2):181-188. PubMed ID: 28008792
    [Abstract] [Full Text] [Related]

  • 20. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease.
    Scheinert D, Schmidt A, Zeller T, Müller-Hülsbeck S, Sixt S, Schröder H, Weiss N, Ketelsen D, Ricke J, Steiner S, Rosenfield K.
    J Endovasc Ther; 2016 Jun 01; 23(3):409-16. PubMed ID: 27117972
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.